Aktiesnakken — December 2009
-
new bio group.....hmmm...oncology.....biologicals......genmab.....hmmmm
-
hear there is more strange stuff to come, so buckle your safety belts!!!
-
jeg ved det godt det er spinkelt, men vi har jo ingenting at gå efter p.t.
-
Det hænger vel sammen med historien om at man vil omrokere 2.200 stillinger.http://www.mmm-online.com/gsk-shifts-2200-posts-for-growth/article/158851/
-
-
de snakker om interne omrokeringer i onc division.
-
Det andet er bare udmeldt strategi på salgssiden, hvor man omlægger fra vest til øst.
-
tkdv 27,50...
-
så for mig har det mere sammenhæng med kræft end med almindelig strategi....
-
nu er genmab i plus igen....
-
87.25
-
heftigt købspres
-
jeg må hellere lige skrive at jeg nu er ude af tkdev igen... så der ikke er nogle der får ondt bagi over noget.
-
cimber 6,25.... godt kaldt aka!
-
aka ka bare det der.. :-)!!
-
hegu er du kommet med ombord i den lille genmab
-
goddag hya...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind